Orally administered manganese chloride: Enhanced detection of hepatic tumors in rats

Burkhard P. Kreft, Yuji Baba, Akihiro Tanimoto, J. Paul Finn, David D. Stark

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

To evaluate its potential as a tissue-specific hepatobiliary magnetic resonance (MR) contrast agent, manganese chloride was orally administered to rats in increasing doses of 100-1,500 μmol/kg MnCl2, and the relaxation times of liver, pancreas, kidney, and heart were measured with ex vivo relaxometry and in vivo MR imaging. Two hours after ingestion of 200 μmol/kg MnCl2, liver T1 was decreased by 48%, whereas tumor T1 decreased by only 9%. On spin-echo MR images, the signal-to-noise ratio in liver increased by 54%; the contrast-to-noise ratio in tumor, by 375%. The T1 of pancreas, kidney, and heart decreased by 8%, 23%, and 13%, respectively. At subjective assessment, the signal intensity of the upper gastrointestinal tract was reduced, likely because of the high concentration of manganese in the lumen, and delineation of the intestine from other abdominal structures was improved. These results indicate that orally administered MnCl2 causes substantial, reproducible, and tissue-specific enhancement of liver. Because enhancement of tumor was minimal, orally administered MnCl2 may potentially be used to improve detection of hepatic tumors.

Original languageEnglish
Pages (from-to)543-548
Number of pages6
JournalRadiology
Volume186
Issue number2
Publication statusPublished - 1993 Feb

Fingerprint

Liver
Neoplasms
Pancreas
Magnetic Resonance Spectroscopy
Kidney
Upper Gastrointestinal Tract
Signal-To-Noise Ratio
Manganese
Contrast Media
Intestines
Noise
Eating
Magnetic Resonance Imaging
manganese chloride

Keywords

  • Contrast media, experimental studies, 761.1229
  • Liver neoplasms, MR, 761.1214
  • Liver, MR, 761.1214
  • Magnetic resonance (MR), relaxometry
  • Manganese, 761.1229

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Kreft, B. P., Baba, Y., Tanimoto, A., Finn, J. P., & Stark, D. D. (1993). Orally administered manganese chloride: Enhanced detection of hepatic tumors in rats. Radiology, 186(2), 543-548.

Orally administered manganese chloride : Enhanced detection of hepatic tumors in rats. / Kreft, Burkhard P.; Baba, Yuji; Tanimoto, Akihiro; Finn, J. Paul; Stark, David D.

In: Radiology, Vol. 186, No. 2, 02.1993, p. 543-548.

Research output: Contribution to journalArticle

Kreft, BP, Baba, Y, Tanimoto, A, Finn, JP & Stark, DD 1993, 'Orally administered manganese chloride: Enhanced detection of hepatic tumors in rats', Radiology, vol. 186, no. 2, pp. 543-548.
Kreft, Burkhard P. ; Baba, Yuji ; Tanimoto, Akihiro ; Finn, J. Paul ; Stark, David D. / Orally administered manganese chloride : Enhanced detection of hepatic tumors in rats. In: Radiology. 1993 ; Vol. 186, No. 2. pp. 543-548.
@article{62f0068edc914c18b18d03f4a24a0d95,
title = "Orally administered manganese chloride: Enhanced detection of hepatic tumors in rats",
abstract = "To evaluate its potential as a tissue-specific hepatobiliary magnetic resonance (MR) contrast agent, manganese chloride was orally administered to rats in increasing doses of 100-1,500 μmol/kg MnCl2, and the relaxation times of liver, pancreas, kidney, and heart were measured with ex vivo relaxometry and in vivo MR imaging. Two hours after ingestion of 200 μmol/kg MnCl2, liver T1 was decreased by 48{\%}, whereas tumor T1 decreased by only 9{\%}. On spin-echo MR images, the signal-to-noise ratio in liver increased by 54{\%}; the contrast-to-noise ratio in tumor, by 375{\%}. The T1 of pancreas, kidney, and heart decreased by 8{\%}, 23{\%}, and 13{\%}, respectively. At subjective assessment, the signal intensity of the upper gastrointestinal tract was reduced, likely because of the high concentration of manganese in the lumen, and delineation of the intestine from other abdominal structures was improved. These results indicate that orally administered MnCl2 causes substantial, reproducible, and tissue-specific enhancement of liver. Because enhancement of tumor was minimal, orally administered MnCl2 may potentially be used to improve detection of hepatic tumors.",
keywords = "Contrast media, experimental studies, 761.1229, Liver neoplasms, MR, 761.1214, Liver, MR, 761.1214, Magnetic resonance (MR), relaxometry, Manganese, 761.1229",
author = "Kreft, {Burkhard P.} and Yuji Baba and Akihiro Tanimoto and Finn, {J. Paul} and Stark, {David D.}",
year = "1993",
month = "2",
language = "English",
volume = "186",
pages = "543--548",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",

}

TY - JOUR

T1 - Orally administered manganese chloride

T2 - Enhanced detection of hepatic tumors in rats

AU - Kreft, Burkhard P.

AU - Baba, Yuji

AU - Tanimoto, Akihiro

AU - Finn, J. Paul

AU - Stark, David D.

PY - 1993/2

Y1 - 1993/2

N2 - To evaluate its potential as a tissue-specific hepatobiliary magnetic resonance (MR) contrast agent, manganese chloride was orally administered to rats in increasing doses of 100-1,500 μmol/kg MnCl2, and the relaxation times of liver, pancreas, kidney, and heart were measured with ex vivo relaxometry and in vivo MR imaging. Two hours after ingestion of 200 μmol/kg MnCl2, liver T1 was decreased by 48%, whereas tumor T1 decreased by only 9%. On spin-echo MR images, the signal-to-noise ratio in liver increased by 54%; the contrast-to-noise ratio in tumor, by 375%. The T1 of pancreas, kidney, and heart decreased by 8%, 23%, and 13%, respectively. At subjective assessment, the signal intensity of the upper gastrointestinal tract was reduced, likely because of the high concentration of manganese in the lumen, and delineation of the intestine from other abdominal structures was improved. These results indicate that orally administered MnCl2 causes substantial, reproducible, and tissue-specific enhancement of liver. Because enhancement of tumor was minimal, orally administered MnCl2 may potentially be used to improve detection of hepatic tumors.

AB - To evaluate its potential as a tissue-specific hepatobiliary magnetic resonance (MR) contrast agent, manganese chloride was orally administered to rats in increasing doses of 100-1,500 μmol/kg MnCl2, and the relaxation times of liver, pancreas, kidney, and heart were measured with ex vivo relaxometry and in vivo MR imaging. Two hours after ingestion of 200 μmol/kg MnCl2, liver T1 was decreased by 48%, whereas tumor T1 decreased by only 9%. On spin-echo MR images, the signal-to-noise ratio in liver increased by 54%; the contrast-to-noise ratio in tumor, by 375%. The T1 of pancreas, kidney, and heart decreased by 8%, 23%, and 13%, respectively. At subjective assessment, the signal intensity of the upper gastrointestinal tract was reduced, likely because of the high concentration of manganese in the lumen, and delineation of the intestine from other abdominal structures was improved. These results indicate that orally administered MnCl2 causes substantial, reproducible, and tissue-specific enhancement of liver. Because enhancement of tumor was minimal, orally administered MnCl2 may potentially be used to improve detection of hepatic tumors.

KW - Contrast media, experimental studies, 761.1229

KW - Liver neoplasms, MR, 761.1214

KW - Liver, MR, 761.1214

KW - Magnetic resonance (MR), relaxometry

KW - Manganese, 761.1229

UR - http://www.scopus.com/inward/record.url?scp=0027390712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027390712&partnerID=8YFLogxK

M3 - Article

C2 - 8421762

AN - SCOPUS:0027390712

VL - 186

SP - 543

EP - 548

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 2

ER -